P2.12-04. The Role of Serum Proteomic Signature in Predicting Survival in PD-L1 Low Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor (ICI)
Back to course
Pdf Summary
Asset Subtitle
Youjin Oh, United States
Meta Tag
Speaker Youjin Oh, United States
Topic Tumour Biology and Biomarkers - Immune Biology & Immunotherapy
blood-based proteomic test
survival prediction
non-small cell lung cancer
PD-L1 expression
immune checkpoint inhibitor
machine learning
mass spectrometry
proteomic signature
Powered By